-
1
-
-
36549011407
-
-
Geneva UNAIDS-WHO
-
UNAIDS. AIDS epidemic update, December, 2002. Geneva UNAIDS-WHO, 2002. http://www.unaids.org/worldaidsday/2002/press/Epiupdate.html (accessed March 6, 2003).
-
(2002)
AIDS Epidemic Update, December, 2002
-
-
-
2
-
-
0028003766
-
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
-
Connor E., Sperling R., Gelber R., et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 331:1994;1173-1180.
-
(1994)
N Engl J Med
, vol.331
, pp. 1173-1180
-
-
Connor, E.1
Sperling, R.2
Gelber, R.3
-
3
-
-
0029558404
-
Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of a Markov model: The HIV Infection in Newborns French Collaborative Study Group
-
Rouzioux C., Costagliola D., Burgard M., et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 transmission by use of a Markov model: the HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol. 142:1995;1330-1337.
-
(1995)
Am J Epidemiol
, vol.142
, pp. 1330-1337
-
-
Rouzioux, C.1
Costagliola, D.2
Burgard, M.3
-
4
-
-
19244362947
-
Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast feeding population in Kinshasha, Zaire
-
Bertolli J., St Louis M.E., Simonds R.J., et al. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast feeding population in Kinshasha, Zaire. J Infect Dis. 174:1996;722-726.
-
(1996)
J Infect Dis
, vol.174
, pp. 722-726
-
-
Bertolli, J.1
St Louis, M.E.2
Simonds, R.J.3
-
5
-
-
0033528527
-
Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: A randomised trial
-
Wiktor S.Z., Ekpini E., Karon J.M., et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial. Lancet. 353:1999;781-785.
-
(1999)
Lancet
, vol.353
, pp. 781-785
-
-
Wiktor, S.Z.1
Ekpini, E.2
Karon, J.M.3
-
6
-
-
0033528521
-
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: A double-blind placebo-controlled multicentre trial
-
Dabis F., Msellati P., Meda N., et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. Lancet. 353:1999;786-792.
-
(1999)
Lancet
, vol.353
, pp. 786-792
-
-
Dabis, F.1
Msellati, P.2
Meda, N.3
-
7
-
-
0033528520
-
Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial
-
Shaffer N., Chuachoowong R., Mock P.A., et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet. 353:1999;773-780.
-
(1999)
Lancet
, vol.353
, pp. 773-780
-
-
Shaffer, N.1
Chuachoowong, R.2
Mock, P.A.3
-
8
-
-
0032511919
-
Mother-to-child transmission of HIV: Implications of variation in maternal infectivity
-
Dunn D.T., Tess B.H., Rodrigues L.C., Ades A.E. Mother-to-child transmission of HIV: implications of variation in maternal infectivity. AIDS. 12:1998;2211-2216.
-
(1998)
AIDS
, vol.12
, pp. 2211-2216
-
-
Dunn, D.T.1
Tess, B.H.2
Rodrigues, L.C.3
Ades, A.E.4
-
9
-
-
0032558333
-
International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection
-
Leroy V., Newell M.L., Dabis F., et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet. 352:1998;597-600.
-
(1998)
Lancet
, vol.352
, pp. 597-600
-
-
Leroy, V.1
Newell, M.L.2
Dabis, F.3
-
10
-
-
0033603802
-
HIV transmission from breastfeeding: A study in Malawi
-
Miotti P.G., Taha T.E.T., Kumwenda N.I., et al. HIV transmission from breastfeeding: a study in Malawi. JAMA. 282:1999;744-749.
-
(1999)
JAMA
, vol.282
, pp. 744-749
-
-
Miotti, P.G.1
Taha, T.E.T.2
Kumwenda, N.I.3
-
11
-
-
10544245018
-
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
-
Sperling R.S., Shapiro D.E., Coombs R.W., et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Eng J Med. 335:1998;1621-1629.
-
(1998)
N Eng J Med
, vol.335
, pp. 1621-1629
-
-
Sperling, R.S.1
Shapiro, D.E.2
Coombs, R.W.3
-
12
-
-
0033523454
-
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
-
Guay L., Musoke P., Fleming T., et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 354:1999;795-802.
-
(1999)
Lancet
, vol.354
, pp. 795-802
-
-
Guay, L.1
Musoke, P.2
Fleming, T.3
-
13
-
-
0018687930
-
A multi-stage procedure for clinical trials
-
O'Brien P.C., Fleming T.R. A multi-stage procedure for clinical trials. Biometrics. 35:1979;549-556.
-
(1979)
Biometrics
, vol.35
, pp. 549-556
-
-
O'Brien, P.C.1
Fleming, T.R.2
-
14
-
-
0032419597
-
Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection
-
Pollard R.B., Robinson P., Dransfield K. Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin Ther. 20:1998;1071-1092.
-
(1998)
Clin Ther
, vol.20
, pp. 1071-1092
-
-
Pollard, R.B.1
Robinson, P.2
Dransfield, K.3
-
15
-
-
0034614136
-
Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers
-
Sha B.E., Proia L., Kessler H.A. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA. 284:2000;2723-2724.
-
(2000)
JAMA
, vol.284
, pp. 2723-2724
-
-
Sha, B.E.1
Proia, L.2
Kessler, H.A.3
-
16
-
-
0035799102
-
Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1
-
Benn P.D., Mercey D.E., Brink N., Scott G., William I.G. Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1. Lancet. 357:2001;687-688.
-
(2001)
Lancet
, vol.357
, pp. 687-688
-
-
Benn, P.D.1
Mercey, D.E.2
Brink, N.3
Scott, G.4
William, I.G.5
-
17
-
-
0000544290
-
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - Worldwide, 1997-2000
-
Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures - worldwide, 1997-2000. MMWR Morb Mortal Wkly Rep. 49:2001;1153-1156.
-
(2001)
MMWR Morb Mortal Wkly Rep
, vol.49
, pp. 1153-1156
-
-
-
18
-
-
17344368990
-
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates
-
Mirochnick M., Fenton T., Gagnier P., et al. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. J Infect Dis. 178:1998;368-374.
-
(1998)
J Infect Dis
, vol.178
, pp. 368-374
-
-
Mirochnick, M.1
Fenton, T.2
Gagnier, P.3
-
19
-
-
0033545463
-
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected Ugandan women and their neonates (HIVNET 006)
-
Musoke P., Guay L., Bagenda D., et al. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected Ugandan women and their neonates (HIVNET 006). AIDS. 13:1999;479-486.
-
(1999)
AIDS
, vol.13
, pp. 479-486
-
-
Musoke, P.1
Guay, L.2
Bagenda, D.3
-
20
-
-
0037055088
-
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: A randomized trial
-
Dorenbaum A., Cunningham C.K., Gelber R.D., et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 288:2002;189-198.
-
(2002)
JAMA
, vol.288
, pp. 189-198
-
-
Dorenbaum, A.1
Cunningham, C.K.2
Gelber, R.D.3
-
21
-
-
0037333802
-
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1
-
Moodley D., Moodley J., Coovadia H., et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 187:2003;725-735.
-
(2003)
J Infect Dis
, vol.187
, pp. 725-735
-
-
Moodley, D.1
Moodley, J.2
Coovadia, H.3
-
22
-
-
0037029419
-
Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania,South Africa, and Uganda (Petra study): A randomised, double blind, placebo-controlled trial
-
Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania,South Africa, and Uganda (Petra study): a randomised, double blind, placebo-controlled trial. Lancet. 359:2002;1178-1186.
-
(2002)
Lancet
, vol.359
, pp. 1178-1186
-
-
-
23
-
-
0032511952
-
Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus
-
Wade N.A., Birkhead G.S., Warren B. L., et al. Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus. N Engl J Med. 339:1998;1409-1414.
-
(1998)
N Engl J Med
, vol.339
, pp. 1409-1414
-
-
Wade, N.A.1
Birkhead, G.S.2
Warren B., L.3
-
24
-
-
0037159519
-
US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States
-
US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Wkly Rep. 51:2002;1-40. http://AIDSInfo.nih.gov accessed March 6, 2003.
-
(2002)
MMWR Morb Mortal Wkly Rep
, vol.51
, pp. 1-40
-
-
-
25
-
-
0036239507
-
Effectiveness of potent antiretroviral therapies onreducing perinatal transmission of HIV-1
-
Cooper E., Charurat M., Mofenson L., et al. Effectiveness of potent antiretroviral therapies onreducing perinatal transmission of HIV-1. J Acquir Immune Defic Syndr Human Retrovirol. 29:2002;484-494.
-
(2002)
J Acquir Immune Defic Syndr Human Retrovirol
, vol.29
, pp. 484-494
-
-
Cooper, E.1
Charurat, M.2
Mofenson, L.3
-
26
-
-
0034161409
-
Effect of breast feeding and formula feeding on transmission of HIV-1
-
Nduati R., John G., Mbori-Ngacha D., et al. Effect of breast feeding and formula feeding on transmission of HIV-1. JAMA. 283:2000;1167-1174.
-
(2000)
JAMA
, vol.283
, pp. 1167-1174
-
-
Nduati, R.1
John, G.2
Mbori-Ngacha, D.3
-
27
-
-
0035895633
-
Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: Prospective cohort study from Durban, South Africa
-
Coutsoudis A., Pillay K., Kuhn L., et al. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 15:2001;379-387.
-
(2001)
AIDS
, vol.15
, pp. 379-387
-
-
Coutsoudis, A.1
Pillay, K.2
Kuhn, L.3
-
28
-
-
0033816265
-
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
-
Jackson J.B., Becker-Pergola G., Guay L., et al. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS. 14:2000;F111-F115.
-
(2000)
AIDS
, vol.14
-
-
Jackson, J.B.1
Becker-Pergola, G.2
Guay, L.3
-
29
-
-
0035913939
-
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)
-
Eshleman S.H., Mracna M., Guay L.A., et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS. 15:2001;1951-1957.
-
(2001)
AIDS
, vol.15
, pp. 1951-1957
-
-
Eshleman, S.H.1
Mracna, M.2
Guay, L.A.3
-
30
-
-
0033523387
-
The cost-effectiveness of a single dose nevirapine regimen to mother and infant to reduce vertical HIV transmission in Uganda
-
Marseille E., Kahn J., Mmiro F., et al. The cost-effectiveness of a single dose nevirapine regimen to mother and infant to reduce vertical HIV transmission in Uganda. Lancet. 354:1999;803-809.
-
(1999)
Lancet
, vol.354
, pp. 803-809
-
-
Marseille, E.1
Kahn, J.2
Mmiro, F.3
-
32
-
-
85031081677
-
Protocol MPH NEV-7: Prevention of the mother-to-child transmission of HIV
-
Durban, South Africa, July: abstr LbPeC7086
-
Sousselier M, Sousselier B, Arouko H. Protocol MPH NEV-7: prevention of the mother-to-child transmission of HIV. XIII International AIDS Conference, Durban, South Africa, July 2000: abstr LbPeC7086.
-
(2000)
XIII International AIDS Conference
-
-
Sousselier, M.1
Sousselier, B.2
Arouko, H.3
-
33
-
-
0037446414
-
Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings
-
Stringer J.S.A., Sinkala M., Stout J.P., et al. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. JAcquir Immune Defic Syndr. 32:2003;506-513.
-
(2003)
JAcquir Immune Defic Syndr
, vol.32
, pp. 506-513
-
-
Stringer, J.S.A.1
Sinkala, M.2
Stout, J.P.3
-
34
-
-
0043129064
-
Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine
-
Stringer J.S.A., Sinkala M., Chapman V., et al. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS. 17:2003;1659-1665.
-
(2003)
AIDS
, vol.17
, pp. 1659-1665
-
-
Stringer, J.S.A.1
Sinkala, M.2
Chapman, V.3
|